Alaunos Therapeutics flags Nasdaq noncompliance after stockholders’ equity falls below 2,500,000

Alaunos Therapeutics, Inc. -1.81%

Alaunos Therapeutics, Inc.

TCRT

2.71

-1.81%

  • Alaunos Therapeutics received a Nasdaq notice on April 9, 2026 for failing to meet Listing Rule 5550(b)(1) minimum stockholders’ equity requirement of $2.5 million.
  • Form 10-K for fiscal 2025 showed stockholders’ equity of $2.2 million.
  • Nasdaq gave Alaunos until May 26, 2026 to submit a compliance plan.
  • Acceptance of plan could allow up to 180 days from April 9, 2026 to regain compliance.
  • Failure to regain compliance could trigger delisting process, with option to request a Nasdaq hearings panel review that would stay suspension pending outcome.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alaunos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-157126), on April 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.